Related Experiment Videos
Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
Abstract:
Despite an increasing understanding of immunological mechanisms it is still not clear how tumors evade immune-surveillance of the host and how tumors interact with the immune-system. In particular, the question whether tumors arise because of an insufficient immune response or whether tumor cells employ active strategies to escape the control of the immune system is still open. Data from a great number of in vitro studies and animal models offer arguments for both the theory of an immune escape as well as that of tumor tolerance. In this article the available results regarding the mechanisms of host-tumor-interaction are discussed with focus on these two contrary hypotheses.
Insights
Tumors may evade immune surveillance through active escape strategies or due to a weak host immune response. This review discusses host-tumor interactions and immune evasion mechanisms.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- The precise mechanisms by which tumors evade host immune surveillance remain incompletely understood.
- It is debated whether tumor development results from insufficient immune response or active tumor cell evasion strategies.
Purpose of the Study:
- To review and discuss the available data on host-tumor interactions.
- To focus on the two contrasting hypotheses of immune escape and tumor tolerance.
Main Methods:
- Review of in vitro studies.
- Analysis of animal models.
- Discussion of existing literature on host-tumor interaction.
Main Results:
- Evidence supports both active immune escape by tumors and tumor tolerance due to host immune factors.
- In vitro and animal studies provide arguments for both theories.
Conclusions:
- The interaction between tumors and the immune system is complex, involving both active evasion and host-related factors.
- Further research is needed to elucidate the dominant mechanisms of tumor immune evasion and tolerance.